Share-Based Payments (Details) (USD $)	3 Months Ended					9 Months Ended					9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		9 Months Ended		3 Months Ended	9 Months Ended
	Sep. 30, 2012		Jun. 30, 2012	Sep. 30, 2011		Sep. 30, 2012		Sep. 30, 2011		Dec. 31, 2011	Sep. 30, 2012 Share Exchange Consulting Warrants ($45.00 exercise price) [Member]	Dec. 31, 2011 Share Exchange Consulting Warrants ($45.00 exercise price) [Member]	Sep. 30, 2012 2007 Private Placement Broker Warrants ($45.00 exercise price) [Member]	Dec. 31, 2011 2007 Private Placement Broker Warrants ($45.00 exercise price) [Member]	Sep. 30, 2012 2007 Private Placement Investor Warrants ($150.00 exercise price) [Member]	Dec. 31, 2011 2007 Private Placement Investor Warrants ($150.00 exercise price) [Member]	Sep. 30, 2012 July 2010 Sinotop Acquisition Warrants ($45.00 exercise price) [Member]	Dec. 31, 2011 July 2010 Sinotop Acquisition Warrants ($45.00 exercise price) [Member]	Sep. 30, 2012 July 2010 Sinotop Acquisition Warrants ($150.00 exercise price) [Member]	Dec. 31, 2011 July 2010 Sinotop Acquisition Warrants ($150.00 exercise price) [Member]	Sep. 30, 2012 May 2011 Warner Brothers Warrants ($6.60 excercise price) [Member]	Dec. 31, 2011 May 2011 Warner Brothers Warrants ($6.60 excercise price) [Member]	Sep. 30, 2012 June 2011 Fidelity Right to Purchase ($6.60 exercise price) [Member]	Dec. 31, 2011 June 2011 Fidelity Right to Purchase ($6.60 exercise price) [Member]	Sep. 30, 2012 2011 Service Agreement Warrants ($7.20 exercise price) [Member]	Dec. 31, 2011 2011 Service Agreement Warrants ($7.20 exercise price) [Member]	Sep. 30, 2012 2012 August Financing Warrants ($4.25 exercise price) [Member]	Dec. 31, 2011 2012 August Financing Warrants ($4.25 exercise price) [Member]	Jun. 30, 2011 Restricted Stock [Member]	Sep. 30, 2012 Stock Options [Member]	Sep. 30, 2012 2010 Stock Incentive Plan [Member]
Share-Based Payments [Abstract]
Stock option amortization	$ 192,000	[1]		$ 150,000	[1]	$ 602,000	[1]	$ 442,000	[1]
Stock issued for services	139,000	[2]		0	[2]	178,000	[2]	10,000	[2]
Stock issued to certain consultants for services	101,542	[2]
Shares vested	43,972	[2]				43,972	[2]
Stock warrants issued for services	10,000			0		36,000		12,000
Right to purchase shares	0			0		44,000		155,000
Total share based payments expense	341,000			150,000		860,000		619,000
Fair Value Assumptions and Methodology [Abstract]
Risk-free interest rate minimum (in hundredths)						1.73%		1.73%
Risk free interest rate maximum (in hundredths)						3.43%		3.43%
Expected volatility minimum (in hundredths)						60.00%		60.00%
Expected volatility maximum (in hundredths)						75.00%		75.00%
Expected life						10 years		10 years
Expected dividend yield (in hundredths)						0.00%		0.00%
Number of Independent Members Appointed to Board of Directors			2
Number of Independent Directors Granted Restricted Shares			3
Restricted shares granted (in shares)																													10,000
Vesting period																													1 year
Number of shares authorized (in shares)																															4,000,000
Stock option activity, shares [Roll Forward]
Options outstanding at beginning of year (in shares)																														1,383,567
Granted (in shares)																														227,567
Exercised (in shares)																														(1,347)
Cancelled/expired (in shares)																														(8,542)
Options outstanding at end of period (in shares)																														1,601,245
Options exercisable at end of period (in shares)																														1,012,198
Options available for issuance (in shares)																														2,398,755
Stock option activity, weighted average exercise price [Roll Forward]
Options outstanding at beginning of year (in dollars per share)																														$ 3.32
Granted (in dollars per share)																														$ 4.48
Exercised (in dollars per share)																														$ 3.80
Cancelled/expired (in dollars per share)																														$ 4.20
Options outstanding at end of period (in dollars per share)																														$ 3.51
Options exercisable at end of period (in dollars per share)																														$ 3.32
Stock option activity, aggregate intrinsic value [Roll forward]
Options outstanding at beginning of year																														1,016,867
Granted																														0
Exercised																														(63)
Cancelled/expired																														(170)
Options outstanding at end of period (in shares)																														1,016,634
Options exercisable at end of period																														732,047
Weighted average remaining contractual life																														8 years 3 months
Total unrecognized compensation expense related to options granted	$ 1,618,000					$ 1,618,000
Unrecognized compensation expense related to options grant, recognition period						4 years
Class of Warrant or Right [Line Items]
Number of warrants outstanding (in shares)	1,420,642					1,420,642				433,579	59,664	59,664	8,533	8,533	53,333	53,333	17,049	17,049	13,333	13,333	200,000	200,000	75,000	75,000	16,667	6,667	977,063	0
Exercise price (in dollars per share)	$ 14.02					$ 14.02					$ 45.00		$ 45.00		$ 150.00		$ 45.00		$ 150.00		$ 6.60		$ 6.60		$ 7.20		$ 4.25
Weighted average remaining life						4 years 0 months 10 days
Expiration date											Jan. 11, 2013		Jan. 11, 2013		Jan. 11, 2013		Jan. 11, 2013		Jan. 11, 2013		May 11, 2016		Dec. 03, 2012		Jun. 15, 2016		Aug. 30, 2017

[1] The Company accounts for its stock option awards pursuant to the provisions of ASC 718, Stock Compensation. The fair value of each option award is estimated on the date of grant using the Black-Scholes Merton valuation model. The Company recognizes the fair value of each option as compensation expense ratably using the straight-line attribution method over the service period, which is generally the vesting period. The Black-Scholes Merton model incorporated the following assumptions for the options granted in 2012 and 2011: risk-free interest rate of 1.73% to 3.43%, expected volatility of 60% and 75%, expected life of 10.0 years and expected dividend yield of 0%.

[2] In the second quarter of 2012, the Company appointed two new "independent" (as defined under the NASDAQ listing requirements) members to the Board of Directors. In connection with the appointment we granted each of our three "independent" directors 10,000 restricted shares to be vested quarterly over one year. In the third quarter of 2012, the Company issued shares to certain consultants for services. We recorded the common shares at the closing price on the issue date and expensed to consulting and marketing services $139,000 and $178,000 during the three and nine months ended September 30, 2012. During the three and nine months ended September 30, 2011, we recorded $10,000 for other consulting services.